Biotech | March 16, 2024
Evonik Vland Biotech JV commences operations
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
It is the first autotaxin inhibitor to be investigated in cancer patients
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Sustainability is integral to Biocon's business purpose
The agreement sets terms under which POC will manufacture the product or receive royalties
Subscribe To Our Newsletter & Stay Updated
